Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy

European Journal of Haematology

Volumn 74, Issue 3, 2005, Pages 263-266

  Jordan, Karin ^a   Grothey, Axel ^a   Grothe, Wilfried ^a   Kegel, Thomas ^a   Wolf, Hans Heinrich ^a   Schmoll, Hans Joachim ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

CD20; EBV associated lymphoproliferative disease; Liebow granulomatosis; Lymphomatoid granulomatosis; Mediastinal bulk; Rituximab

Indexed keywords

ALPHA INTERFERON; RITUXIMAB; TRACER; VALGANCICLOVIR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER REGRESSION; CASE REPORT; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HUMAN; LYMPHOMATOID GRANULOMATOSIS; MEDIASTINUM MASS; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR CELL;

ADULT; ANTIBODIES, MONOCLONAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMATOID GRANULOMATOSIS; MAGNETIC RESONANCE IMAGING; MEDIASTINAL NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 14044256512     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00367.x     Document Type: Article

References (19)

1. LIEBOW AA, CARRINGTON CR, FRIEDMAN PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558.
2. FAUCI AS, HAYNES BF, COSTA J, KATZ P, WOLFF SM. Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med 1982;306:68-74.
3. BEATY MW, TORO J, SORBARA L, et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol 2001;25:1111-1120.
4. SALDANA MJ, PATCHEFSKY AS, ISRAEL HI, ATKINSON GW. Pulmonary angiitis and granulomatosis. The relationship between histological features, organ involvement, and response to treatment. Hum Pathol 1977;8:391-409.
5. NICHOLSON AG, WOTHERSPOON AC, DISS TC, et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology 1996;29:317-324.
6. SAXENA A, DYKER KM, ANGEL S, MOSHYNSKA O, DHARAMPAUL S, COCKROFT DW. Posttransplant diffuse large B-cell lymphoma of 'lymphomatoid granulomatosis' type. Virchows Arch 2002;441:622-628.
7. BOHLE M, RASCHE K, MULLER KM, SCHULTZE-WERNINGHAUS G, FISSELER-ECKHOFF A. Lymphomatoid granulomatosis: differential diagnosis and therapy. Med Klin 1999;94:513-519.
8. JAFFE ES, WILSON WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv 1997;30:233-248.
9. WILSON WH, KINGMA DW, RAFFELD M, WITTES RE, JAFFE ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 1996;87:4531-4537.
10. BERNSTEIN ML, REECE ER, de CHADAREVIAN JP, KOCH PA. Bone marrow transplantation in lymphomatoid granulomatosis. Report of a case. Cancer 1986;58:969-972.
11. BALDI A, GROEGER AM, ESPOSITO V, et al. Lymphomatoid granulomatosis of the lung: a clinico-pathological study. Anticancer Res 1998;18(6B):4621-4624.
12. KATZENSTEIN AL, PEIPER SC. Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique. Mod Pathol 1990;3:435-441.
13. RIE H, JUNICHI N, NAOMI Y, TERUAKI O, KEN O. A case report of lymphomatoid granulomatosis (LYG) with spontaneous attenuation. Nihon Rinsho Meneki Gakkai Kaishi 2002;25:199-204.
14. KATZENSTEIN AL, CARRINGTON CB, LIEBOW AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360-373.
15. PASSAS A, JAGANNATH S, DESIKAN KR, et al. Lymphomatoid granulomatosis following autologous stem cell transplantation. Bone Marrow Transplant 1999;23:79-81.
16. BOYE J, ELTER T, ENGERT A. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 2003;14:520-535.
17. REFF ME, CARNER K, CHAMBERS KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994;83:435-445.
18. ANDERSON DR, GRILLO-LOPEZ A, VARNS C, CHAMBERS KS, HANNA N. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans 1997;25:705-708.
19. TEDDER TF, ENGEL P. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 1994;15: 450-454.